Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

NCT04518228 · clinicaltrials.gov ↗

COMPLETED

Status

205

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Tuberculosis

Interventions

DRUG: Bictegravir (BIC)
DRUG: Tenofovir alafenamide (TAF)
DRUG: Cabotegravir (CAB)
DRUG: Dolutegravir (DTG)
DRUG: Atazanavir/ritonavir (ATV/r)
DRUG: Darunavir/ritonavir (DRV/r)
DRUG: Lopinavir/ritonavir (LPV/r)
DRUG: Cobicistat
DRUG: Ritonavir
DRUG: First-Line TB Treatment
DRUG: Second-Line TB Treatment
DRUG: Doravirine (DOR)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]